Newsroom | 57187 results

ZUGO, Svizzera--(BUSINESS WIRE)--Polpharma Biologics, leader biofarmaceutico specializzato nello sviluppo e nella produzione di biosimilari, annuncia con entusiasmo la sigla di un importante accordo di licenza con la brasiliana Libbs Farmacêutica. Grazie a questa partnership strategica, Libbs Farmacêutica otterrà i diritti esclusivi di commercializzazione relativi a un avanzato biosimilare mirato alle malattie autoimmuni nel mercato brasiliano, in rapida espansione. Polpharma Biologics manterrà...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nick Gennari brings three decades of supply-chain and regulated material management leadership to GXP-Storage's Board of Directors....

ZUG, Suíça--(BUSINESS WIRE)--A Polpharma Biologics, empresa biofarmacêutica líder especializada no desenvolvimento e fabricação de biossimilares, tem o prazer de anunciar a assinatura de um acordo de licenciamento histórico com a empresa brasileira Libbs Farmacêutica! Por meio dessa parceria estratégica, a Libbs Farmacêutica obterá direitos exclusivos para comercializar um biossimilar de ponta para doenças autoimunes no mercado brasileiro, que está em rápido crescimento. A Polpharma Biologics m...

ZUG, Zwitserland--(BUSINESS WIRE)--Polpharma Biologics, een toonaangevend biofarmaceuticabedrijf gespecialiseerd in de ontwikkeling en productie van biosimilars, kondigt met genoegen de ondertekening aan van een belangrijke licentieovereenkomst met het Braziliaanse bedrijf Libbs Farmacêutica. Via dit strategische partnerschap verwerft Libbs Farmacêutica exclusieve rechten om een baanbrekende biosimilar voor auto-immuunziekten te commercialiseren in de snel groeiende Braziliaanse markt. Polpharm...

ZUG、スイス--(BUSINESS WIRE)--（ビジネスワイヤ） -- バイオシミラーの開発および製造を専門とする大手バイオ医薬品企業である Polpharma Biologics は、ブラジルの企業 Libbs Farmacêutica と画期的なライセンス契約を締結したことを大変喜ばしく発表します。この戦略的パートナーシップを通じて、Libbs Farmacêutica は急成長するブラジル市場において、自己免疫疾患向けの最先端バイオシミラーを独占的に販売する権利を取得します。 Polpharma Biologics は、バイオシミラーの開発および製造に関する全責任を引き続き負います。Libbs Farmacêutica は、ブラジルにおけるバイオシミラーの商業化、マーケティング、および流通に関する独占的ライセンスを保有します。この協業は、新たなエキサイティングな機会を切り開くものであり、両社が革新的でアクセスしやすい治療を患者に届けるという共通のコミットメントを示しています。 「バイオシミラーでブラジル市場に参入することは、Polpharma Biologics にとって...

PITTSBURGH--(BUSINESS WIRE)--Intelligent power management company Eaton today announced it will open a new manufacturing campus in Henrico County, Virginia, for critical power distribution technologies to help meet record demand from data center customers. With more than 50 new data centers already permitted in Virginia this year, Eaton is increasing regional manufacturing for technologies vital to data center equipment uptime and reliability. The company will more than double its footprint in...

HOUSTON--(BUSINESS WIRE)--Evers & Sons Inc. has been selected as a 2025 Work Safe, Texas Award recipient by Texas Mutual Insurance Company. The award presentation took place December 9, 2025, recognizing the company for its ongoing commitment to workplace safety and employee well-being. Evers & Sons received recognition in Texas Mutual’s highest award category, Platinum Safety Partner, a distinction awarded to only 200 companies each year out of more than 81,000 policyholders statewide....

MELBOURNE, Fla.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) has been awarded a follow-on production contract valued up to $200 million to manufacture Guided Multiple Launch Rocket System (GMLRS) Insensitive Munition (IM) propulsion units. The GMLRS IM contract will be the first order processed through L3Harris’ newly constructed facility in Camden, Arkansas, which was funded through the Defense Production Act Title III cooperative agreement and enables annual production capacity to incr...

MIRAMAR, Fla.--(BUSINESS WIRE)--CITEL, a global expert in surge protection, proudly announces the relocation of its US headquarters to Hillsborough, NC....

SAN DIEGO--(BUSINESS WIRE)--Airgain signs partnership agreement with U.S. based telecom systems integrator to support the rollout of Lighthouse™ Smart 5G NCR nationwide....